67 related articles for article (PubMed ID: 1936482)
1. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.
Vigneri R; Trischitta V; Italia S; Mazzarino S; Rabuazzo MA; Squatrito S
Diabete Metab; 1991 May; 17(1 Pt 2):232-4. PubMed ID: 1936482
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?
Trischitta V; Italia S; Raimondo M; Guardabasso V; Licciardello C; Runello F; Mazzarino S; Sangiorgi L; Anello M; Vigneri R
J Endocrinol Invest; 1998 Dec; 21(11):744-7. PubMed ID: 9972673
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.
Niazi R; Muzaffar Z
J Pak Med Assoc; 1998 Nov; 48(11):336-8. PubMed ID: 10323055
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined therapies in treatment of secondary failure to glyburide.
Trischitta V; Italia S; Mazzarino S; Buscema M; Rabuazzo AM; Sangiorgio L; Squatrito S; Vigneri R
Diabetes Care; 1992 Apr; 15(4):539-42. PubMed ID: 1499473
[TBL] [Abstract][Full Text] [Related]
6. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
7. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
8. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
De Mattia G; Laurenti O; Moretti A
Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
[TBL] [Abstract][Full Text] [Related]
9. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar].
Sidibé EH; Badiane MK; Gueye A
Sante; 2002; 12(3):319-22. PubMed ID: 12473527
[TBL] [Abstract][Full Text] [Related]
10. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
Klein W
Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
Laurenti O; Bravi MC; Faldetta MC; De Mattia G
Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria].
Sangiorgio L; Rabuazzo MA; Cordaro G; Grasso G; Condorelli L; Lunetta M
Minerva Endocrinol; 1996 Jun; 21(2):47-52. PubMed ID: 9026680
[TBL] [Abstract][Full Text] [Related]
17. Combination daytime chlorpropamide-metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes.
Aguilar CA; Wong B; Gómez-Pérez FJ; Rull JA
Rev Invest Clin; 1992; 44(1):71-6. PubMed ID: 1523352
[TBL] [Abstract][Full Text] [Related]
18. Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.
Trischitta V; Italia S; Borzi V; Tribulato A; Mazzarino S; Squatrito S; Vigneri R
Diabetes Care; 1989 Sep; 12(8):582-5. PubMed ID: 2505990
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
Groop L; Widén E
Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
[TBL] [Abstract][Full Text] [Related]
20. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus.
Groop L; Widén E; Franssila-Kallunki A; Ekstrand A; Saloranta C; Schalin C; Eriksson J
Diabetologia; 1989 Aug; 32(8):599-605. PubMed ID: 2506091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
